Search

Objectives: The study aimed to compare the effects of separate and simultaneous application of Tecar therapy and low-level laser therapy on neurological symptoms of type 2 diabetic patients. Patients and methods: In this randomized control trial conducted between November 2021 and February 2022, 45 patients (30 females, 15 males; mean age: 65.7±7.6 years; range, 51 to 76 years) with type 2 diabetes and peripheral sensory neuropathy of the lower limbs were randomly divided into three groups: Tecar + sham laser (n=15), Tecar + laser (n=15), and laser + sham Tecar (n=15). Outcome measures for both right and left limbs included tibial motor nerve conduction velocity (MNCV), sural nerve amplitude, sole sensation, and ankle-brachial index (ABI) measured before and after 10 sessions and after a three-month follow-up. Results: In intergroup comparison, the Tecar + laser group significantly improved compared to the laser + sham Tecar group in terms of tibial MNCV in both limbs after 10 sessions and all measured outcomes after three months (p<0.05). In addition, comparison between the Tecar + laser and Tecar + sham laser groups for tibial MNCV (p=0.021 for the right limb and p=0.002 for the left limb) and ABI (p=0.001 for the right limb and p=0.002 for the left limb) in both limbs after three months was significant. In the intragroup comparison, a significant improvement was found in the laser + sham Tecar group for sole sensation (p<0.001) and ABI (p<0.001) of both limbs after three months compared to before the interventions, whereas in the other two groups, significant improvements were found in all four outcomes. Conclusion: A significant increase was found in neurological outcomes in all three groups after 10 sessions. Moreover, the use of combined Tecar therapy and laser compared to Tecar or laser alone could lead to a more lasting effect in improving the sensory symptoms of type 2 diabetic patients with peripheral neuropathy of the lower limbs. [ABSTRACT FROM AUTHOR]

Objectives: This study aimed to investigate the effect of Tecar therapy on neuropathy symptoms and tibial nerve conduction velocity in individuals with diabetes. Patients and methods: The single-blind, randomized, sham-controlled clinical trial was conducted between January 2019 and October 2019. Twenty-four type 2 diabetics (8 males, 16 females; mean age: 60.4±8.9 years; range, 40 to 78 years) with peripheral neuropathy were randomly allocated to control (n=12) and study (n=12) groups. The study group received the capacitive Tecar therapy with 10 to 30% intensity and infrared radiation in 10 sessions. The controls received the same protocol with zero intensity. The neuropathy symptoms and nerve conduction velocity were evaluated at baseline, after 10 sessions, and six weeks after the end of sessions. Results: There were no significant differences in variables (p>0.05). In this way, the homogeneity of the data variables was confirmed. Moreover, the results of two-way mixed analysis of variance showed that improvement of neuropathy symptoms in the study group was significantly more than controls in all stages (p<0.001). After 10 sessions, the results of post hoc analysis showed that the neuropathy symptoms and tibial nerve conduction velocity were significantly improved in both groups (p<0.001). The improvements were still present at six weeks in the study group (p<0.05). However, there was no change in these outcomes after six weeks in the control group (p>0.05). Conclusion: Tecar therapy could improve neuropathy symptoms and tibial nerve conduction velocity in diabetic individuals with peripheral neuropathy. Therefore, the use of this method to control the symptoms of diabetic patients can be recommended. [ABSTRACT FROM AUTHOR]

Objective Because of the significant prevalence of diabetes, disability of patients due to the complication of Diabeti Neuropathy (DN) has been increased. Physiotherapy is one of the methods for DN which can help control the symptoms through modalities such as infrared radiation, electrical stimulation and electromagnetic fields. Tecar therapy is a form of electromagnetic fields. This study investigated the effect of Capacitive Tecar therapy on pain and tactile sensation of the feet in type 2 diabetics with symptoms of peripheral neuropathy. Materials & Methods This clinical trial was performed as pre-test and post-test with a control group. The samples consisted of 24 diabetics aged 17-78 years with symtoms of peripheral neuropathy allocated in the control and experimental group randomly. The patients of experimental groups participated in 10 sessions and received the Capasitive tecar therapy with 10%-30% intensity in addition to infrared radiation; the controls received the same protocol with zero intensity of tecar. Pain and tactile sensation of the soles were evaluated before and after sessions. The collected data were analyzed by the Reapeted measure Analysis Of Variance (ANOVA). All statistical analyses were performed in SPSS V. 18. The significance level was set at P<0.05. Results The results of Rearetd Measure ANOVA showed that there was a significant difference in the mean scores of pain and tactile sensation of soles in the post-test compared to the pre-test of two groups. (P<0.001).There was also a significant difference in the means of post-test scores of variable pain (P=0.002) and tactile sensation (P<0.001) between the two groups. The improvement of variables in experimental group was more than control group. Conclusion The results of this study revealed that Tecar Therapy with infrared radiation can be an appropriate therapeutic program for improving pain and tactile sensation of soles in diabetic patients with symptoms of peripheral neuropathy. [ABSTRACT FROM AUTHOR]